Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-04 · accession 0001127602-24-009016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-07 | 2024-03-04+ | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $67.31 | -17.7K | 121.2K | -13% | -$1.19M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | F | D | 9,630 | $67.68 | 133,343 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-06 | F | D | 8,109 | $66.88 | 121,234 | D | — | — |